WEBULL
News
ONWRY
4.700
NaN%
--
ONWARD Medical Reports EUR 1.7 Million Q3 Revenue and Raises Over EUR 50 Million in Equity Capital
Reuters · 11/24/2025 06:30
ONWARD Medical Drives Strong US ARC-EX Adoption and Achieves Important Scientific and Regulatory Milestones in Q3 2025
Barchart · 11/24/2025 00:30
ONWARD MEDICAL RECEIVES FDA 510(K) CLEARANCE EXPANDING ARC-EX SYSTEM INDICATION FOR HOME USE
Reuters · 11/17/2025 06:30
ONWARD Medical Raises EUR 50.85 Million in Private Placement
Reuters · 10/28/2025 16:48
ONWARD Medical Publishes Closing of Bookbuild Offering
Barchart · 10/28/2025 11:45
Ottobock Invests €10 Million in ONWARD Medical
Reuters · 10/24/2025 05:44
ONWARD Medical Raises Over EUR 50 Million in Private Placement
Reuters · 10/24/2025 05:30
ONWARD Medical Successfully Raises Over EUR 50 Million in Capital Increase
Barchart · 10/24/2025 00:30
ONWARD Medical Launches Capital Increase for Indicative Amount of EUR 50 Million
Barchart · 10/22/2025 10:49
ONWARD Medical NV Reports Record Quarterly Revenue, Surpassing EUR 1 Million and Expanding ARC-EX Adoption in Over 50 US Clinics
Reuters · 10/13/2025 05:34
ONWARD Medical NV Reports Quarterly Revenue Exceeding EUR 1 Million and Sells 40 ARC-EX Systems in Q3 2025
Reuters · 10/13/2025 05:30
ONWARD Medical Provides Preliminary Q3 2025 Update Highlighting Accelerating ARC-EX Adoption in the United States
Barchart · 10/13/2025 00:30
BNP Paribas Portzamparc initiates buy rating on ONWARD Medical with EUR 1020 target price
Reuters · 10/08/2025 05:30
Portzamparc – BNP Paribas Group Initiates Coverage of ONWARD Medical with a Buy Rating and Target Price of EUR 10.20
Barchart · 10/08/2025 00:30
ONWARD Medical Announces Launch of Global Pivotal Trial for ARC-IM Therapy to Address Blood Pressure Instability in Spinal Cord Injury Patients
Reuters · 09/18/2025 05:30
Concurrent Publications in Nature and Nature Medicine Highlight Advances in Blood Pressure Regulation after Spinal Cord Injury Using ONWARD ARC-IM Therapy
Barchart · 09/18/2025 00:30
Weekly Report: what happened at ONWRY last week (0908-0912)?
Weekly Report · 09/15/2025 12:35
Weekly Report: what happened at ONWRY last week (0901-0905)?
Weekly Report · 09/08/2025 12:37
ONWARD Medical NV Secures CE Mark Certification for ARC-EX System, Paving Way for European Commercialization
Reuters · 09/08/2025 06:45
ONWARD Medical Receives CE Mark for ARC-EX, Enabling Commercial Launch of Breakthrough Spinal Cord Stimulation System in Europe
Barchart · 09/08/2025 01:44
More
Webull provides a variety of real-time ONWRY stock news. You can receive the latest news about ONWARD Medical NV through multiple platforms. This information may help you make smarter investment decisions.
About ONWRY
Onward Medical NV, formerly known as GTX Medical BV, is a medical technology company based in the Netherlands. The Company is primarily engaged in developing and commercializing innovative therapies to enable functional recovery for people with spinal cord injury. It develops two technology platforms ARC EX and ARC IM.